Five‐year biomarker progression variability for Alzheimer's disease dementia prediction: Can a complex instrumental activities of daily living marker fill in the gaps?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Five‐year biomarker progression variability for Alzheimer's disease dementia prediction: Can a complex instrumental activities of daily living marker fill in the gaps?

Published:2015-11-14 Issue:4 Volume:1 Page:521-532
ISSN:2352-8729
Container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
language:en
Short-container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Author:

Tarnanas Ioannis¹²,Tsolaki Anthoula³,Wiederhold Mark⁴,Wiederhold Brenda⁵,Tsolaki Magda³

Affiliation:

1. Health‐IS LabDepartment of ManagementTechnology and Economics, ETH ZurichZurichSwitzerland

2. Piaget Research FoundationNürnbergGermany

3. 3rd Department of NeurologyMedical School, Aristotle University of ThessalonikiThessalonikiGreece

4. Division of Cognitive and Restorative NeurologyVirtual Reality Medical CenterSan DiegoCAUSA

5. Virtual Reality Medical InstituteClos Chapelle aux ChampsBrusselsBelgium

Funder

European Union's Seventh Framework Programme

Novel Serious Game Diagnostic Marker

Virtual Reality Medical Center, USA

Greek Association for Alzheimer's Disease and Related Disorders

Greek Association for Alzheimer's Disease and Related Disorders Memory Clinics

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.dadm.2015.10.005

Reference48 articles.

1. What lessons can be learned from failed Alzheimer's disease trials?;Toyn J.;Expert Rev Clin Pharmacol,2015

2. The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

3. The transitional association between β‐amyloid pathology and regional brain atrophy

4. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

5. Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and Predictive Factors in Early Alzheimer’s Disease: A Systematic Review;Journal of Alzheimer's Disease Reports;2024-02-16

2. Digital Health Technologies for Alzheimer’s Disease and Related Dementias: Initial Results from a Landscape Analysis and Community Collaborative Effort;The Journal of Prevention of Alzheimer's Disease;2024

3. Augmented reality versus standard tests to assess cognition and function in early Alzheimer’s disease;npj Digital Medicine;2023-12-18

4. Eliciting brain waves of people with cognitive impairment during meditation exercises using portable electroencephalography in a smart-home environment: a pilot study;Frontiers in Aging Neuroscience;2023-05-30

5. Developing Early Markers of Cognitive Decline and Dementia Derived From Survey Response Behaviors: Protocol for Analyses of Preexisting Large-scale Longitudinal Data;JMIR Research Protocols;2023-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3